Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Non-narcotic treatment for migraines

28.12.2004


An inexpensive, non-narcotic medication has been identified as an important step in treating acute migraine headaches, according to a study performed by University of Alberta researchers in collaboration with other emergency physicians.



Researchers from the University of Alberta, University of Cambridge, Michigan State University and British Columbia’s St. Paul’s Hospital are recommending metoclopramide be considered a primary step in treating migraine sufferers who visit the emergency room for treatment.

The medication differs from traditional approaches such as narcotics (morphine or Demerol), because it avoids the risk of addiction to painkillers, noted Dr. Brian Rowe, a professor of emergency medicine at the University of Alberta.


"There is a tendency for patients with migraines to become dependent on narcotics for acute pain relief. Unfortunately, narcotics may reduce the pain acutely, however, they are sedating, usually with adverse effects, are usually not very effective and many patients suffer headache relapses that result in returns to the emergency room for additional care," Dr. Rowe said. "We recommend metoclopramide because it is safe, inexpensive and leads to less dependence on narcotics."

While metoclopramide has previously been used to treat migraines, the evidence was conflicting and this review by Rowe and his fellow researchers has helped clarify approaches for adult patients seeking headache relief in an emergency setting.

Results of the study, which involved reviewing data from 13 trials involving 655 adults, were published this month in the British Medical Journal. In studies comparing metoclopramide with placebos, the medication was 2.8 times more likely to provide significant reduction in migraine. In addition, combination treatments that included metoclopramide were as, or more effective than comparison treatments for migraine pain, nausea and relapse outcomes reported in all studies reviewed by the researchers.

Administered intravenously, metoclopramide proved effective in relieving the nausea that often accompanies a migraine, worked rapidly, was gentle on the stomach and did not cause changes in blood pressure.

Bev Betkowski | EurekAlert!
Further information:
http://www.ualberta.ca

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>